SITIY yields 10.41% · PFE yields 6.13%● Live data
📍 SITIY pulled ahead of the other in Year 1
Combined, SITIY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SITIY + PFE for your $10,000?
SITC International Holdings Company Limited, a shipping logistics company, provides integrated transportation and logistics solutions in Mainland China, Hong Kong, Taiwan, Japan, Southeast Asia, and internationally. It operates through two segments, Container Shipping and Logistics; and Dry Bulk and Others. The Container Shipping and Logistics segment offers container transportation, freight forwarding, shipping agency, and depot and warehousing services. The Dry Bulk and Others segment provides dry bulk vessel and land leasing, as well as air freight forwarding services. As of December 31, 2021, the company operated a fleet of 96 vessels with a total capacity of 143,115 TEU, including 68 self-owned vessels with a capacity of 103,663 TEU and 28 chartered vessels with a capacity of 39,452 TEU; and 5 dry bulk vessels with a total tonnage of 362,000 tons. It also offers container and vessel holding, and chartering; technology support; container maintenance; customs declaration; and multimodal transportation services. The company was founded in 1991 and is headquartered in Wan Chai, Hong Kong. SITC International Holdings Company Limited is a subsidiary of Resourceful Link Management Limited.
Full SITIY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.